Tumor Biology

, Volume 35, Issue 10, pp 10051–10056 | Cite as

Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A)

  • Li-Ya Su
  • Hong-Yi Xin
  • Yong-Lei Liu
  • Jia-Ling Zhang
  • Hong-Wu Xin
  • Xiu-Lan Su
Research Article


Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in vitro and gastric tumors in vivo via repressing cell growth and promoting apoptosis, making it a promising potential biological anticancer drug. However, it is not known what genes are functionally required for the ACBP effects. Here, we first found that two tumor suppressor genes, cyclin-dependent kinase inhibitor 2B (CDKN2B) and growth arrest and DNA damage-inducible alpha (GADD45A), were upregulated significantly in the cells with ACBP treatment by microarray screening and the findings were validated by real-time RT-PCR. Next, GADD45A mRNA and protein expressions were downregulated in the gastric cancer cells by lentivirus-mediated RNAi; then, cell viability, cell cycle, and apoptosis were assayed by MTT and flow cytometry. Interestingly, our results indicated that cell viability was not dependent on GADD45A without ACBP treatment; however, cell sensitivity to ACBP was significantly decreased in ACBP-treated gastric cancer cells with GADD45A downregulation. Therefore, we demonstrate that GADD45A was functionally required for ACBP to inhibit gastric cancer cells, suggesting that GADD45A may become a biomarker for ACBP sensitivity. Our findings have significant implications on the molecular mechanism understanding, biomarker development, and anticancer drug development of ACBP.


Anticancer bioactive peptide Gastric cancer Cell viability Apoptosis Cell cycle CDKN2B GADD45A 



This research was supported by the National Natural Science Foundation (81160254).


  1. 1.
    Ren JS, Li Q, Guan P, Dai M, Yang L. Estimation and prediction for incidence, mortality and prevalence of common gastrointestinal tract cancers in China, in 2008. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;33(10):1052–5. PubMed PMID: 23290850.PubMedGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30. PubMed PMID:16514137.CrossRefPubMedGoogle Scholar
  3. 3.
    Hou JF, Yan MR, Yan XH, Jiao TM, Rong YN, Su XL. Effect of anti-cancer bioactive peptide on leukemia mice. J Inn Mong Med Coll. 2004;26(1):3–6.Google Scholar
  4. 4.
    Yang ZY, Wang WL, Su XL. HPCE analysis of polypeptides isolated from goat spleens. Chin J Pharm Anal. 2005;10:1248–9.Google Scholar
  5. 5.
    Yang ZY, Zhang ZP, Su XL. MALDI-TOF-MS analysis of polypeptides isolated from goat spleens. Chin Pharm J. 2005;10:797.Google Scholar
  6. 6.
    Xu GH, Su XL, Shen JF, Bi, Xiaohui O. Control of anti-cancer bioactive peptide on the cell cycle of gastric cancer BGC-823. Chin J Clin Oncol. 2007;14:1361–4.Google Scholar
  7. 7.
    Zhao YY, Peng SD, Su XL. Effects of anti-cancer bioactive peptide on cell cycle in human nasopharyngeal carcinoma strain CNE. Chin J Otorhinolaryngol Head Neck Surg. 2006;41:607–11.Google Scholar
  8. 8.
    Jia SQ, Wang WL, Su XL. Inhibitory effect of anti-cancer bioactive peptide on proliferation of human breast cancer cell line nm231. Chin Med Biotechnol. 2007;2:270–5.Google Scholar
  9. 9.
    Su XL, Ying X, Cui HM, et al. And the mechanism of anti-cancer bioactive peptide on GBC-SD gallbladder cancer cells. Acta Anat Sin. 2007;38(Suppl):39–42.Google Scholar
  10. 10.
    Wang ZY, Yang CW, Oy XH, Su XL. Anti-cancer bioactive peptide-S induced apoptosis of hepatoma cells and cell cycle regulation. Chin J Lab Diagn. 2010;14:1–6.Google Scholar
  11. 11.
    Su X, Dong C, Zhang J, Su L, Wang X, Cui H, et al. Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer. Cell Biosci. 2014;4:7.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Williams GH, Stoeber K. The cell cycle and cancer. J Pathol. 2012;226:352–64.CrossRefPubMedGoogle Scholar
  13. 13.
    Miller JP, Yeh N, Vidal A, Koff A. Interweaving the cell cycle machinery with cell differentiation. Cell Cycle. 2007;6:2932–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, et al. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations. Breast Cancer Res Treat. 2010;121:157–67.CrossRefPubMedGoogle Scholar
  15. 15.
    Gujuluva CN, Baek JH, Shin KH, Cherrick HM, Park NH. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene. 1994;9:1819–27.PubMedGoogle Scholar
  16. 16.
    Salvador JM, Brown-Clay JD, Fornace Jr AJ. Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol. 2013;793:1–19.CrossRefPubMedGoogle Scholar
  17. 17.
    Liebermann DA, Tront JS, Sha X, Mukherjee K, Mohamed-Hadley A, Hoffman B. Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog. 2011;16:129–40.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Su L, Xu G, Shen J, Tuo Y, Zhang X, Jia S, et al. Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol Rep. 2010;23:3–9.PubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Clinical Medicine Research Center of the Affiliated HospitalInner Mongolia Medical UniversityHohhotChina
  2. 2.Biomolecular Function Discovery Division, Bioinformatics Institute, Biomedical Sciences InstitutesAgency for Science, Technology and Research (A*STAR)SingaporeSingapore
  3. 3.Department of Biochemistry and Molecular Biology, Shanghai Medical CollegeFudan UniversityShanghaiPeople’s Republic of China

Personalised recommendations